Start shopping and find your next favourite medicine.
Browse Catalog
Minoxidil 5mg + Finasteride 1mg is a once-daily oral combination treatment for male pattern hair loss (androgenetic alopecia), pairing two drugs with different mechanisms: finasteride blocks the hormone (DHT) that causes follicle shrinkage, while minoxidil increases scalp blood flow to stimulate regrowth. This combination is for men only and is not suitable for women, particularly those who are or may become pregnant. A 12-month UK retrospective study of 502 men using a similar oral minoxidil-finasteride combination found 92.4% achieved stable or improved hair density, with 57.4% showing marked improvement.
| Attribute | Details |
|---|---|
| Active Ingredients | Minoxidil 5mg + Finasteride 1mg |
| Drug Classes | Potassium channel opener (minoxidil) + 5-alpha-reductase inhibitor (finasteride) |
| Indication | Male androgenetic alopecia (male pattern hair loss) |
| Who It’s For | Adult men only — not suitable for women |
| Dose | One tablet once daily, same time each day, with or without food |
| Time to Results | Initial changes typically at 3–6 months; full results assessed at 12 months |
| Form / Route | Oral tablet — do not crush or chew |
| Prescription | Required in all markets |
Finasteride blocks 5-alpha-reductase, the enzyme that converts testosterone into DHT — the hormone responsible for shrinking hair follicles in male pattern baldness — while minoxidil widens blood vessels and opens potassium channels to increase blood flow to the scalp and extend the hair growth (anagen) phase. Because the two drugs work on different parts of the hair-loss process, combining them addresses both the cause (DHT) and the follicle environment (blood flow), which is why combination therapy is increasingly preferred over either drug alone.
A 2025 UK retrospective study followed 502 men using a combined oral minoxidil-finasteride regimen for 12 months and found 92.4% achieved stable or improved hair density, with 57.4% showing marked improvement. The study also noted that baseline hair-loss severity (Norwood stage) influenced the size of the improvement, with earlier-stage patients generally seeing better outcomes. This builds on decades of separate evidence for each drug individually — finasteride for slowing DHT-driven hair loss, and minoxidil for stimulating regrowth — with real-world data increasingly supporting the combination as more effective and convenient than either drug alone.
The most commonly reported side effects are mild and include temporary increased shedding in the first 2–3 months, scalp or facial hair changes, and rare sexual side effects associated with finasteride.
Initial visible changes typically appear at 3–6 months, with full results best assessed at the 12-month mark. Some men notice temporary increased shedding in the first 2–3 months before improvement begins — this is a normal part of the hair cycle transition.
No. Finasteride is not approved for use in women, particularly those who are or may become pregnant, due to the risk of harm to a male fetus. Women seeking treatment for pattern hair loss should speak to a doctor about alternative options.
Yes — periodic blood pressure monitoring is recommended for the minoxidil component, and men with a history of depression or mood changes should have regular check-ins regarding mood and sexual function while on finasteride.
Hair loss benefits from both finasteride and minoxidil are not permanent — stopping treatment typically reverses the gains within months, so ongoing use is needed to maintain results.
Real-world and clinical evidence increasingly supports combination therapy as more effective than monotherapy, since finasteride addresses the hormonal cause of hair loss while minoxidil independently stimulates follicle activity — two different mechanisms working together rather than overlapping.
Store at 15–30°C, away from sunlight and moisture. Keep out of reach of children and away from women who are or may become pregnant — finasteride tablets should not be handled by pregnant women, even when intact.
Medically reviewed. Last updated: [20/06/2026]. This content is for informational purposes and does not replace consultation with a licensed physician.
Orders ship from our India Head Office within 1–2 business days of confirmation. We include full customs documentation — HS codes, certificates of origin, and pharmaceutical export permits.
Estimated delivery: 3–7 business days to UK. 7–10 business days to UAE, Saudi Arabia and Gulf countries. 10–15 days for USA and Asian countries.
All packages arrive in plain, unmarked brown boxes. No pharmacy name or medication details on the outside.
Reviews
There are no reviews yet